Company Filing History:
1 out of 1,928 
1 out of 15 Years Active: 2014
Title: The Innovations of Martin Flajnik
Introduction
Martin Flajnik is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding domains. His work has implications for various applications in immunology and therapeutic development.
Latest Patents
Flajnik holds a patent for a process related to the production of antigen specific antigen binding domains. This innovative process utilizes a transformed host containing an expressible DNA sequence that encodes the antigen specific antigen binding domain. Notably, the domain is derived from a variable region of the immunoglobulin isotype NAR found in fish. This patent highlights his expertise in genetic engineering and antibody development.
Career Highlights
Throughout his career, Martin Flajnik has been associated with prestigious institutions such as the University System of Maryland and Aberdeen University. His work at these institutions has allowed him to advance research in immunology and contribute to the scientific community.
Collaborations
Flajnik has collaborated with notable colleagues, including Helen Dooley and Andrew Porter. These partnerships have fostered innovation and have been instrumental in his research endeavors.
Conclusion
Martin Flajnik's contributions to the field of biotechnology through his patent and collaborations underscore his role as a significant inventor. His work continues to influence advancements in immunology and therapeutic applications.